Prosthetic Valve Endocarditis in Surgical vs. Transcatheter Aortic Valve Replacement

摘要

Transcatheter and surgical aortic valve replacement carry the same overall risk for prosthetic valve endocarditis. Transcatheter aortic valve replacement (TAVR) is increasingly used to treat patients with critical aortic valve stenosis who are deemed too high risk to undergo surgical valve replacement (SAVR). The relative risk for prosthetic valve endocarditis (PVE) in patients undergoing TAVR versusJSAVR has not been definitively studied in multicenter trials. To examine this risk, researchers examined a pooled cohort of 8530 patients from PARTNER trials and registries.